If You'd Invested $1,000 in IOVA 3 Years Ago, Here's How Much You'd Have Today

For a roller-coaster stock, look no further than Iovance Biotherapeutics (NASDAQ: IOVA).This company in the inherently volatile biotech sector peaked after getting its first drug approved by the Food and Drug Administration (FDA). Almost as quickly, it dove in price following less positive developments. Let's take a glance at why this cancer-focused drug developer has been so up-and-down, and whether it has the chance of ascending meaningfully again. Since that burst of optimism following said approval, Iovance shares have generally been on a downward trajectory -- $1,000 invested in the company only three years ago would have melted to barely over $219 today.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool